← All Climb Bio, INC filings

Climb Bio, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
CLYM
Climb Bio, INC
SCHEDULE: RA Capital Management Amends Climb Bio Stake
RA Capital Management, L.P. and its affiliates have updated their Schedule 13D filing, reporting a beneficial ownership of 33.0% in Climb Bio, Inc. following a board appointment and stock distribution.
NASDAQ
CLYM
Climb Bio, INC
SCHEDULE: RA Capital Increases Stake in Climb Bio via PIPE
RA Capital Management disclosed a significant investment in Climb Bio, Inc. through a private placement of common stock and pre-funded warrants.
NASDAQ
CLYM
Climb Bio, INC
SCHEDULE: RA Capital Adjusts Climb Bio Stake, Converts Shares to Warrants
RA Capital Management and affiliated funds have amended their Schedule 13D filing for Climb Bio, Inc., converting a significant portion of common stock into pre-funded warrants and detailing recent open market purchases.
NASDAQ
CLYM
Climb Bio, INC
SCHEDULE: Access Industries Fully Divests Climb Bio Stake
Access Industries and its affiliates have fully divested their beneficial ownership in Climb Bio, Inc., selling over 3.8 million shares in recent block trades.
NASDAQ
CLYM
Climb Bio, INC
SCHEDULE: Climb Bio Major Shareholder Reduces Stake
Access Industries entities and Len Blavatnik have reduced their beneficial ownership in Climb Bio, Inc. to 5.66% through recent share sales.